[HTML][HTML] Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
Consensus definitions have been reached for both acute kidney injury (AKI) and chronic
kidney disease (CKD) and these definitions are now routinely used in research and clinical …
kidney disease (CKD) and these definitions are now routinely used in research and clinical …
Perioperative acute kidney injury
SD Gumbert, F Kork, ML Jackson, N Vanga… - …, 2020 - pubs.asahq.org
Perioperative organ injury is among the leading causes of morbidity and mortality of surgical
patients. Among different types of perioperative organ injury, acute kidney injury occurs …
patients. Among different types of perioperative organ injury, acute kidney injury occurs …
Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney …
MS Davenport, MA Perazella, J Yee, JR Dillman… - Radiology, 2020 - pubs.rsna.org
Intravenous iodinated contrast media are commonly used with CT to evaluate disease and
to determine treatment response. The risk of acute kidney injury (AKI) developing in patients …
to determine treatment response. The risk of acute kidney injury (AKI) developing in patients …
ESPEN guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease
E Fiaccadori, A Sabatino, R Barazzoni, JJ Carrero… - Clinical Nutrition, 2021 - Elsevier
Acute kidney disease (AKD)-which includes acute kidney injury (AKI)–and chronic kidney
disease (CKD) are highly prevalent among hospitalized patients, including those in …
disease (CKD) are highly prevalent among hospitalized patients, including those in …
Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with covid-19 and seasonal influenza: cohort study
Comparative evaluation of clinical manifestations and risk of death in patients admitted to
hospital with covid-19 and seasonal Page 1 the bmj | BMJ 2020;371:m4677 | doi: 10.1136/bmj.m4677 …
hospital with covid-19 and seasonal Page 1 the bmj | BMJ 2020;371:m4677 | doi: 10.1136/bmj.m4677 …
[HTML][HTML] Trial of vancomycin and cefazolin as surgical prophylaxis in arthroplasty
Background The addition of vancomycin to beta-lactam prophylaxis in arthroplasty may
reduce surgical-site infections; however, the efficacy and safety are unclear. Methods In this …
reduce surgical-site infections; however, the efficacy and safety are unclear. Methods In this …
[HTML][HTML] Outcomes after angiography with sodium bicarbonate and acetylcysteine
SD Weisbord, M Gallagher, H Jneid… - … England Journal of …, 2018 - Mass Medical Soc
Background Intravenous sodium bicarbonate and oral acetylcysteine are widely used to
prevent acute kidney injury and associated adverse outcomes after angiography without …
prevent acute kidney injury and associated adverse outcomes after angiography without …
Acute kidney injury 2016: diagnosis and diagnostic workup
M Ostermann, M Joannidis - Critical care, 2016 - Springer
Acute kidney injury (AKI) is common and is associated with serious short-and long-term
complications. Early diagnosis and identification of the underlying aetiology are essential to …
complications. Early diagnosis and identification of the underlying aetiology are essential to …
Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review
Importance Because early-stage kidney disease is asymptomatic and is associated with
both morbidity and mortality, laboratory measurements are required for its detection …
both morbidity and mortality, laboratory measurements are required for its detection …
Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections
RK Shields, BA Potoski, G Haidar, B Hao… - Clinical Infectious …, 2016 - academic.oup.com
Thirty-seven carbapenem-resistant Enterobacteriaceae (CRE)-infected patients were treated
with ceftazidime-avibactam. Clinical success and survival rates at 30 days were 59%(22/37) …
with ceftazidime-avibactam. Clinical success and survival rates at 30 days were 59%(22/37) …